These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 32269942)
1. Exosomes in clinical trial and their production in compliance with good manufacturing practice. Chen YS; Lin EY; Chiou TW; Harn HJ Ci Ji Yi Xue Za Zhi; 2020; 32(2):113-120. PubMed ID: 32269942 [TBL] [Abstract][Full Text] [Related]
2. Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes. Zhang F; Zhang L; Yu H Curr Stem Cell Res Ther; 2024; 19(9):1195-1209. PubMed ID: 38523514 [TBL] [Abstract][Full Text] [Related]
3. A review on exosomes application in clinical trials: perspective, questions, and challenges. Rezaie J; Feghhi M; Etemadi T Cell Commun Signal; 2022 Sep; 20(1):145. PubMed ID: 36123730 [TBL] [Abstract][Full Text] [Related]
4. Manufacturing Therapeutic Exosomes: from Bench to Industry. Ahn SH; Ryu SW; Choi H; You S; Park J; Choi C Mol Cells; 2022 May; 45(5):284-290. PubMed ID: 35534190 [TBL] [Abstract][Full Text] [Related]
5. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects. Ma CY; Zhai Y; Li CT; Liu J; Xu X; Chen H; Tse HF; Lian Q Med Res Rev; 2024 May; 44(3):919-938. PubMed ID: 38095832 [TBL] [Abstract][Full Text] [Related]
6. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method. Andriolo G; Provasi E; Lo Cicero V; Brambilla A; Soncin S; Torre T; Milano G; Biemmi V; Vassalli G; Turchetto L; Barile L; Radrizzani M Front Physiol; 2018; 9():1169. PubMed ID: 30197601 [TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Exosome from Human Embryonic Stem Cell-Derived C-Myc-Immortalized Mesenchymal Stem Cells. Lai RC; Yeo RW; Padmanabhan J; Choo A; de Kleijn DP; Lim SK Methods Mol Biol; 2016; 1416():477-94. PubMed ID: 27236691 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Liu H; Deng S; Han L; Ren Y; Gu J; He L; Liu T; Yuan ZX Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112163. PubMed ID: 34736220 [TBL] [Abstract][Full Text] [Related]
10. Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency. Willis GR; Kourembanas S; Mitsialis SA Front Cardiovasc Med; 2017; 4():63. PubMed ID: 29062835 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis. Kim GB; Shon OJ; Seo MS; Choi Y; Park WT; Lee GW Biology (Basel); 2021 Apr; 10(4):. PubMed ID: 33915850 [TBL] [Abstract][Full Text] [Related]
13. Large-scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture. Duan L; Li X; Xu X; Xu L; Wang D; Ouyang K; Liang Y J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969064 [TBL] [Abstract][Full Text] [Related]
14. MSC exosome works through a protein-based mechanism of action. Toh WS; Lai RC; Zhang B; Lim SK Biochem Soc Trans; 2018 Aug; 46(4):843-853. PubMed ID: 29986939 [TBL] [Abstract][Full Text] [Related]
15. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application. Yamashita T; Takahashi Y; Takakura Y Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069 [TBL] [Abstract][Full Text] [Related]
17. GMP-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer. Arjmand B; Alavi-Moghadam S; Rezaei-Tavirani M; Kokabi-Hamidpour S; Arjmand R; Gilany K; Rajaeinejad M; Rahim F; Namazi N; Larijani B Methods Mol Biol; 2024; 2736():163-176. PubMed ID: 36515892 [TBL] [Abstract][Full Text] [Related]
18. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes. Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554 [TBL] [Abstract][Full Text] [Related]